Eloxx Pharmaceuticals, Inc. (ELOX) Financials

ELOX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 6.0 million 26.1 million
2023-06-30 6.0 million 24.6 million
2023-03-31 7.2 million 23.5 million
2022-12-31 21.1 million 31.8 million

ELOX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.5 million 418000
2023-06-30 -2.1 million 610000
2023-03-31 -6.8 million 597000
2022-12-31 -5.7 million 641000

ELOX Net Income

No data available :(

ELOX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 4.8 million - 318000
2023-06-30 4.3 million - 496000
2023-03-31 4.9 million - 673000
2022-12-31 19.2 million - 847000

ELOX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.7 million
2023-06-30 2.2 million
2023-03-31 2.2 million
2022-12-31 2.2 million

ELOX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.3 million 2.4 million -
2023-06-30 - 2.3 million 1.8 million -
2023-03-31 - 3.5 million 2.0 million -
2022-12-31 18000 3.3 million 2.7 million -

ELOX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

ELOX

Price: $0.85

52 week price:
0.40
10.90

Earnings Per Share: -9.68 USD

P/E Ratio: -0.10

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 67300

Market Capitalization: 3.4 million

Links: